Bluebird bio went public in 2013, raising approximately $116m through its IPO. The company has developed three US Food and Drug Administration (FDA)-approved gene therapy products, including Zynteglo ...

One of the biggest fundamental innovations in the last ten years is the emergence of edge computing as a concept. In reality, ...

"An epic exploration of possibilities. What If is a Webby Award-winning science web series that takes you on a journey through hypothetical worlds and possibilities, some in distant corners of the ...

"This region is uniquely positioned and ready for Vertex's mission with its rich industrial ecosystem and skilled workforce,” ...